Authored By: Sarah
23 Oct 2024

increasing demand for asthma medications is driving the Montelukast Sodium Market

Latest News:- Montelukast Sodium Market: Tablets is expected to lead the Type segment during 2024-2028

Technavio analyzes that the Montelukast Sodium Market is expected to grow at a CAGR of 4.5% during 2023 and 2028. During this period, the market is also expected to show a growth of USD 1340.4 million.There are various factors that contribute to the growth of the market. The Montelukast Sodium market is experiencing significant growth due to the escalating demand for asthma medications. Montelukast Sodium, a leukotriene receptor antagonist, is a popular choice for managing asthma symptoms and preventing asthma exacerbations. Its effectiveness in treating both intermittent and persistent asthma, as well as its convenience as a once-daily dosage medication, contributes to its increasing popularity among healthcare professionals and patients alike. The global market for Montelukast Sodium is anticipated to expand at a robust pace in the coming years, driven by its proven efficacy and the rising prevalence of asthma worldwide.

Montelukast Sodium is primarily available in the form of oral solutions for managing respiratory diseases, particularly in the pediatric population with chronic conditions. This dosage form offers advantages such as ease of administration and quicker onset of action compared to tablets. The patient epidemiology for Montelukast Sodium indicates a significant demand, necessitating a robust pipeline analysis. Healthcare providers prefer oral solutions for their versatility and suitability for younger patients. Despite the convenience, oral solutions are more complex to manufacture than tablets, which are the most common dosage form due to their cost-effectiveness, safety, and efficiency. Tablets are produced by compressing active pharmaceutical ingredients and excipients into hard, solid forms, which may be round, oblong, or disc-shaped. Caplets, a type of oblong tablet, are designed for easier swallowing and may be scored for splitting. Some tablets feature unique coatings to ensure stability and prevent disintegration in the stomach. 

Know which region is leading the market growth by requesting a sample report

Montelukast Sodium Market Segmentation

  • Type
    • Tablets
    • Chewable tablets
    • Oral solutions
  • Geography
    • North America
    • Europe
    • Asia
    • Rest of World (ROW)

Top Performing Companies

As per our research findings, here are some of the key competitors that are leading the industry

  • Apotex Inc.
  • Aurobindo Pharma Ltd.
  • Bio Techne Corp.
  • Cayman Chemical Co
  • Cipla Inc.
  • Glenmark Pharmaceuticals Ltd.
  • Hetero Healthcare Ltd.
  • Hikma Pharmaceuticals Plc
  • Jubilant Pharmova Ltd.
  • Krosyl Pharmaceuticals Pvt. Ltd.
  • Merck and Co. Inc.
  • Morepen Laboratories Ltd.
  • Novartis AG
  • Simson Pharma Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Unichem Laboratories Ltd.
  • Unimark Remedies Ltd.
  • Viatris Inc.

Find out what is trending in the market by accessing the free PDF report

Research Analysis Overview

Montelukast sodium, a leukotriene inhibitor, is an essential medication for treating various chronic noncommunicable diseases (NCDs), including asthma and allergic rhinitis, in children and adults. It comes in dosage forms of tablets and oral solutions. Montelukast sodium is effective for managing exercise-induced asthma, allergic coryza, urticaria, bronchospasm, and other respiratory maladies such as pneumonia, COPD, emphysema, and asthma exacerbations. It is also used to treat emergency department visits due to asthma attacks. The pediatric population, particularly those with chronic conditions, greatly benefit from Montelukast sodium. The pipeline analysis for Montelukast sodium includes Singulair, which is used to prevent asthma attacks and relieve symptoms of allergic rhinitis. Additionally, Montelukast sodium is effective for treating fungal infections and other allergic conditions, such as allergic coryza and urticaria. It is important to note that Montelukast sodium may also be used for managing symptoms of pollution-related respiratory diseases and simple pill forms are available.

Market Research Overview

The Montelukast sodium market, a segment of the specialty chemicals industry, experiences significant growth due to its application in the treatment of asthma and other noncommunicable diseases, particularly chronic respiratory conditions in children. As the global population grapples with an increasing burden of chronic diseases, the demand for Montelukast sodium as a leukotriene modifier intake for symptomatic relief continues to rise. This market expansion is driven by the shift towards specialized treatments for NCDs and the production of Montelukast sodium in various dosage forms, including tablets, oral solution, and granules. The specialty chemicals market, encompassing high-value-added chemicals used in manufacturing a wide range of products, will witness continued expansion, with Montelukast sodium being a key contributor. The market's growth is fueled by the rising demand for specialty adhesives and sealants, as well as the increasing need for Montelukast sodium in the pharmaceutical sector.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.

Reasons to Consider Purchasing Technavio Market Research Report

  • Current Market Insights: Our reports offer valuable information on the latest market intelligence, competitor strategies, trends, industry changes, customer preferences, and forecasted market opportunities to aid in informed business decisions.

  • Extensive Experience: With over 20 years in market research, Technavio is a trusted name, having published more than 21,000 reports across various industries and regions.

  • High ROI Through In-Depth Research: Technavio specializes in tailored market research reports to meet specific business needs, exploring particular markets, product segments, and demographics. We are also recognized for delivering significant returns on investment through our comprehensive data collection at affordable prices.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/

Read News Read Less
Interested in this report?
Get your sample now!
Technavio